Evaluation of Serratus Plane Block on the Respiratory Pattern in Patients With Multiple Rib Fractures

Sponsor
Niguarda Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05105399
Collaborator
(none)
72
1
3
15.9
4.5

Study Details

Study Description

Brief Summary

In patients admitted following a trauma, the incidence of multiple rib fractures is reported to be 9,7%, and this can be even higher in high energy trauma like motor vehicle accidents (1). Pain deriving from rib fractures cause the patient to breath shallow in order to limit discomfort and this bring about negative consequences: shallow breathing and inability to clear secretions may cause pulmonary atelectasis eventually evolving to pneumonia. Given the aforementioned concerns, it is easy to understand why, in a context like this, control of chest pain become crucial. The best way to achieve adequate pain control have not yet been established: the aim of this study is to investigate on this clinical dilemma. In this study, 72 people with at least two monolateral rib fractures are going to be randomized into three groups: 1) standard treatment alone (intravenous analgesia: acetaminophen + morphine PCA); 2) continuous serratus plane block + standard treatment; 3) single-shot serratus plane block + standard treatment. The variables that are going to be recorded are the following: pain through the NRS scale, FEV1 and FVC through spirometry and finally an arterious gas analysis. Recording are going to be repeated at 72h after admission. The primary endpoint is to evaluate if the continuous serratus plane block is able to improve the FEV1/FVC compared to single shot or standard treatment alone. Secondary endpoints will be: the effect of continuous block on 1) resting and incident pain; 2) opioid consumption; 3) blood gas analysis parameters; 4) pulmonary complications at 1 month; 5) length of stay

Condition or Disease Intervention/Treatment Phase
  • Procedure: Serratus plane block (continuous or single-shot)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Serratus Plane Block on the Respiratory Pattern in Patients With Multiple Rib Fractures: a Perspective Randomized Controlled Study
Anticipated Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Morphine

Active Comparator: Continuous

Procedure: Serratus plane block (continuous or single-shot)
Patients assigned to the interventional arms will receive either continuous serratus plane block or single-shot serratus plane block

Active Comparator: Single

Procedure: Serratus plane block (continuous or single-shot)
Patients assigned to the interventional arms will receive either continuous serratus plane block or single-shot serratus plane block

Outcome Measures

Primary Outcome Measures

  1. FEV1 (% of the predicted value) [72 hours]

    Any statistically significant difference between the two treatment groups and the control group will be measured. FEV1 is expected to be respectively 80±15% of the predicted value in the treatment groups and 64±15% of the predicted value in the control group

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Chest trauma with at least 2 monolateral rib fractures (monofocal or multifocal) with no flail chest

  2. Age>18 years

  3. Hospital admission

  4. Ability to provide written informed consensus

  5. Awake patient, spontaneous ventilation

Contacts and Locations

Locations

Site City State Country Postal Code
1 ASST GOM Niguarda Milano Italy 20162

Sponsors and Collaborators

  • Niguarda Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Niguarda Hospital
ClinicalTrials.gov Identifier:
NCT05105399
Other Study ID Numbers:
  • SAP Versione 2 del 05/06/2020
First Posted:
Nov 3, 2021
Last Update Posted:
Nov 3, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 3, 2021